Next 10 |
home / stock / vktx / vktx articles
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 31.7% on an annualized basis producing an average annual ret...
On Wednesday, the stocks of Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) and Sagimet Biosciences Inc (NASDAQ:SGMT) are trading lower. At the EASL Int...
Viking Therapeutics Inc (NASDAQ:VKTX) released 52-week histologic data from its Phase 2b VOYAGE study of VK2809 in patients with biopsy-confirmed...
Viking Therapeutics (NASDAQ: VKTX), a clinical-stage company focused on developing novel therapeutics for metabolic and endocrine disorders, has be...
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 44.59% on an annualized basis producing an average annual re...
Viking Therapeutics, Inc. (NASDAQ:VKTX) reported its first-quarter financial results after the bell Wednesday. Here's a look at the highlights...
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 38.64% on an annualized basis producing an average annual re...
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 35.1% on an annualized basis producing an average annual ret...
Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter...
News, Short Squeeze, Breakout and More Instantly...
Viking Therapeutics Inc. Company Name:
VKTX Stock Symbol:
NASDAQ Market:
Viking Therapeutics Inc. Website:
2024-07-01 08:15:00 ET Few biotech companies have made more noise than Viking Therapeutics (NASDAQ: VKTX) this year, and that's saying something. The drugmaker had been a relatively small and unknown player in the industry. However, Viking's prominence and stock price soared thanks ...
2024-06-30 06:53:00 ET Altimmune (NASDAQ: ALT) and Viking Therapeutics (NASDAQ: VKTX) have a lot of features in common, but, at least for the moment, the performance of their stocks is not one of them. Whereas Viking's shares are up by 610% over the last three years, Altimmu...